{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000439","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.106388+00:00","generated_at":"2026-06-20T17:58:30.045256+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Prelude Therapeutics files corporate presentation; no specific new details provided","bullets":["Prelude Therapeutics made a corporate presentation available to investors on January 9, 2023.","The presentation was furnished under Regulation FD but its substantive content was not disclosed.","No changes to revenue, EPS, pipeline status, or corporate strategy were announced.","The filing does not contain any new material information beyond the existence of the presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000439","json":"https://secwatch.observer/filing/0000950170-23-000439.json","markdown":"https://secwatch.observer/filing/0000950170-23-000439.md","text":"https://secwatch.observer/filing/0000950170-23-000439.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/0000950170-23-000439-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000095017023000439/prld-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:58:30.045256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}